Credit Suisse Upgrades Medtronic (MDT) to Outperform
More News related to MDT
- Medtronic Donates Medical Supplies to Haiti Relief Effort
- AAHFN Promotes Heart Failure Awareness Week Through Webinar
- Study Suggests Slide-On(R) EndoSheath(R) System Provides Several Advantages over Traditional Germicidal Immersion
- Medtronic Announces Two Late Breaking Clinical Trials Accepted for American College of Cardiology Meeting
- Medtronic Receives FDA Approval for First Replacement Heart Valve Implanted without Surgery
More News related to Upgrades
- RBC Capital Upgrades Spectra Energy (SE) to Outperform
- CL King Upgrades ADC Telecommunications (ADCT) to Strong Buy
- RBC Capital Upgrades Sierra Wireless (SWIR) to Outperform
- Sidoti & Co Upgrades NCI, Inc. (NCIT) to Buy
- Stifel Nicolaus Upgrades Canadian National Railway (CNI) to Buy
Credit Suisse upgrades Medtronic, Inc. (NYSE: MDT) from Neutral to Outperform.
Medtronic, Inc. develops, manufactures, and sells device-based medical therapies worldwide.
Related Categories
UpgradesStocks Mentioned
+0.93Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
